nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—urinary bladder cancer	0.429	1	CbGaD
Ticlopidine—MPO—Carboplatin—urinary bladder cancer	0.0931	0.239	CbGbCtD
Ticlopidine—MPO—Cisplatin—urinary bladder cancer	0.0795	0.204	CbGbCtD
Ticlopidine—CYP2B6—Thiotepa—urinary bladder cancer	0.064	0.164	CbGbCtD
Ticlopidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0197	0.0505	CbGbCtD
Ticlopidine—CYP2B6—Cisplatin—urinary bladder cancer	0.0177	0.0453	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—urinary bladder cancer	0.0176	0.0452	CbGbCtD
Ticlopidine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0158	0.0404	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—urinary bladder cancer	0.0132	0.0337	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0122	0.0313	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0118	0.0304	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—urinary bladder cancer	0.011	0.0282	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—urinary bladder cancer	0.0102	0.0261	CbGbCtD
Ticlopidine—CYP2C9—Cisplatin—urinary bladder cancer	0.00934	0.024	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00572	0.0147	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—urinary bladder cancer	0.00533	0.0137	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00364	0.00933	CbGbCtD
Ticlopidine—P2RY12—prostate gland—urinary bladder cancer	0.00317	0.105	CbGeAlD
Ticlopidine—CYP2C19—urine—urinary bladder cancer	0.0026	0.0862	CbGeAlD
Ticlopidine—P2RY12—epithelium—urinary bladder cancer	0.00233	0.0773	CbGeAlD
Ticlopidine—CYP1A2—urine—urinary bladder cancer	0.00212	0.0704	CbGeAlD
Ticlopidine—CYP2C9—urine—urinary bladder cancer	0.00201	0.0668	CbGeAlD
Ticlopidine—CYP2E1—urine—urinary bladder cancer	0.00191	0.0633	CbGeAlD
Ticlopidine—CYP3A4—urine—urinary bladder cancer	0.00154	0.051	CbGeAlD
Ticlopidine—CYP2D6—urine—urinary bladder cancer	0.00151	0.0502	CbGeAlD
Ticlopidine—MPO—epithelium—urinary bladder cancer	0.00102	0.0339	CbGeAlD
Ticlopidine—MPO—renal system—urinary bladder cancer	0.000949	0.0315	CbGeAlD
Ticlopidine—CYP2E1—prostate gland—urinary bladder cancer	0.000685	0.0227	CbGeAlD
Ticlopidine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00058	0.0192	CbGeAlD
Ticlopidine—CYP2C8—renal system—urinary bladder cancer	0.000555	0.0184	CbGeAlD
Ticlopidine—CYP1A1—epithelium—urinary bladder cancer	0.000552	0.0183	CbGeAlD
Ticlopidine—CYP1A2—renal system—urinary bladder cancer	0.000519	0.0172	CbGeAlD
Ticlopidine—CYP1A1—renal system—urinary bladder cancer	0.000512	0.017	CbGeAlD
Ticlopidine—CYP1A1—urethra—urinary bladder cancer	0.000503	0.0167	CbGeAlD
Ticlopidine—CYP2B6—renal system—urinary bladder cancer	0.000498	0.0165	CbGeAlD
Ticlopidine—CYP2E1—renal system—urinary bladder cancer	0.000467	0.0155	CbGeAlD
Ticlopidine—CYP2C19—vagina—urinary bladder cancer	0.00046	0.0153	CbGeAlD
Ticlopidine—CYP2E1—urethra—urinary bladder cancer	0.000459	0.0152	CbGeAlD
Ticlopidine—CYP2C8—female reproductive system—urinary bladder cancer	0.000444	0.0147	CbGeAlD
Ticlopidine—MPO—lymph node—urinary bladder cancer	0.000444	0.0147	CbGeAlD
Ticlopidine—CYP1A1—female reproductive system—urinary bladder cancer	0.00041	0.0136	CbGeAlD
Ticlopidine—CYP2C8—vagina—urinary bladder cancer	0.000402	0.0133	CbGeAlD
Ticlopidine—CYP2B6—female reproductive system—urinary bladder cancer	0.000399	0.0132	CbGeAlD
Ticlopidine—CYP2C9—female reproductive system—urinary bladder cancer	0.000395	0.0131	CbGeAlD
Ticlopidine—CYP3A4—renal system—urinary bladder cancer	0.000376	0.0125	CbGeAlD
Ticlopidine—CYP2E1—female reproductive system—urinary bladder cancer	0.000374	0.0124	CbGeAlD
Ticlopidine—CYP1A1—vagina—urinary bladder cancer	0.000371	0.0123	CbGeAlD
Ticlopidine—CYP2D6—renal system—urinary bladder cancer	0.00037	0.0123	CbGeAlD
Ticlopidine—CYP2B6—vagina—urinary bladder cancer	0.000361	0.012	CbGeAlD
Ticlopidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000301	0.00999	CbGeAlD
Ticlopidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000296	0.00983	CbGeAlD
Ticlopidine—Arthropathy—Epirubicin—urinary bladder cancer	0.000288	0.00348	CcSEcCtD
Ticlopidine—Vasculitis—Methotrexate—urinary bladder cancer	0.000287	0.00346	CcSEcCtD
Ticlopidine—Epistaxis—Fluorouracil—urinary bladder cancer	0.000284	0.00343	CcSEcCtD
Ticlopidine—Renal failure—Cisplatin—urinary bladder cancer	0.000281	0.00338	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00028	0.00338	CcSEcCtD
Ticlopidine—Pancytopenia—Etoposide—urinary bladder cancer	0.000279	0.00336	CcSEcCtD
Ticlopidine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000276	0.00333	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000276	0.00333	CcSEcCtD
Ticlopidine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000275	0.00332	CcSEcCtD
Ticlopidine—Nausea—Mitomycin—urinary bladder cancer	0.000274	0.00331	CcSEcCtD
Ticlopidine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000272	0.00328	CcSEcCtD
Ticlopidine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00027	0.00326	CcSEcCtD
Ticlopidine—Arthropathy—Doxorubicin—urinary bladder cancer	0.000267	0.00322	CcSEcCtD
Ticlopidine—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00026	0.00314	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000259	0.00313	CcSEcCtD
Ticlopidine—Renal failure—Etoposide—urinary bladder cancer	0.000257	0.0031	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000256	0.00309	CcSEcCtD
Ticlopidine—Ecchymosis—Methotrexate—urinary bladder cancer	0.000253	0.00305	CcSEcCtD
Ticlopidine—Colitis—Epirubicin—urinary bladder cancer	0.000252	0.00303	CcSEcCtD
Ticlopidine—Sepsis—Methotrexate—urinary bladder cancer	0.000243	0.00293	CcSEcCtD
Ticlopidine—Arthralgia—Thiotepa—urinary bladder cancer	0.000242	0.00292	CcSEcCtD
Ticlopidine—Myalgia—Thiotepa—urinary bladder cancer	0.000242	0.00292	CcSEcCtD
Ticlopidine—CYP1A1—lymph node—urinary bladder cancer	0.00024	0.00796	CbGeAlD
Ticlopidine—Tinnitus—Cisplatin—urinary bladder cancer	0.000239	0.00288	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—urinary bladder cancer	0.000237	0.00286	CcSEcCtD
Ticlopidine—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000234	0.00282	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—urinary bladder cancer	0.000233	0.00281	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—urinary bladder cancer	0.000227	0.00274	CcSEcCtD
Ticlopidine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000227	0.00274	CcSEcCtD
Ticlopidine—Hepatic failure—Methotrexate—urinary bladder cancer	0.000226	0.00273	CcSEcCtD
Ticlopidine—Erythema multiforme—Etoposide—urinary bladder cancer	0.000222	0.00268	CcSEcCtD
Ticlopidine—Anorexia—Thiotepa—urinary bladder cancer	0.000221	0.00267	CcSEcCtD
Ticlopidine—Flatulence—Cisplatin—urinary bladder cancer	0.00022	0.00265	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—urinary bladder cancer	0.000219	0.00264	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000219	0.00264	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000216	0.0026	CcSEcCtD
Ticlopidine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000215	0.00259	CcSEcCtD
Ticlopidine—Vascular purpura—Epirubicin—urinary bladder cancer	0.000213	0.00256	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—urinary bladder cancer	0.000212	0.00255	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000212	0.00255	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—urinary bladder cancer	0.00021	0.00254	CcSEcCtD
Ticlopidine—Dyspepsia—Thiotepa—urinary bladder cancer	0.000204	0.00247	CcSEcCtD
Ticlopidine—Arthralgia—Gemcitabine—urinary bladder cancer	0.000204	0.00246	CcSEcCtD
Ticlopidine—Myalgia—Gemcitabine—urinary bladder cancer	0.000204	0.00246	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—urinary bladder cancer	0.000203	0.00245	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000202	0.00244	CcSEcCtD
Ticlopidine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000202	0.00243	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000202	0.00243	CcSEcCtD
Ticlopidine—Myalgia—Fluorouracil—urinary bladder cancer	0.0002	0.00242	CcSEcCtD
Ticlopidine—Pain—Thiotepa—urinary bladder cancer	0.000199	0.00239	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—urinary bladder cancer	0.000197	0.00238	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000197	0.00237	CcSEcCtD
Ticlopidine—Muscle spasms—Etoposide—urinary bladder cancer	0.000197	0.00237	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000196	0.00236	CcSEcCtD
Ticlopidine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000195	0.00236	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000192	0.00232	CcSEcCtD
Ticlopidine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000191	0.00231	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000191	0.0023	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—urinary bladder cancer	0.00019	0.00229	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00019	0.00229	CcSEcCtD
Ticlopidine—Myalgia—Cisplatin—urinary bladder cancer	0.00019	0.00229	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00019	0.00229	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000188	0.00227	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000188	0.00226	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000187	0.00225	CcSEcCtD
Ticlopidine—Anorexia—Gemcitabine—urinary bladder cancer	0.000186	0.00225	CcSEcCtD
Ticlopidine—Urticaria—Thiotepa—urinary bladder cancer	0.000185	0.00222	CcSEcCtD
Ticlopidine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000184	0.00221	CcSEcCtD
Ticlopidine—Anorexia—Fluorouracil—urinary bladder cancer	0.000183	0.00221	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—urinary bladder cancer	0.000183	0.0022	CcSEcCtD
Ticlopidine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000182	0.0022	CcSEcCtD
Ticlopidine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000178	0.00215	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000178	0.00215	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000177	0.00213	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000176	0.00212	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000176	0.00212	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000176	0.00212	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000175	0.00211	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—urinary bladder cancer	0.000174	0.0021	CcSEcCtD
Ticlopidine—Anorexia—Cisplatin—urinary bladder cancer	0.000174	0.00209	CcSEcCtD
Ticlopidine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000171	0.00206	CcSEcCtD
Ticlopidine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00017	0.00205	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000169	0.00204	CcSEcCtD
Ticlopidine—Pain—Gemcitabine—urinary bladder cancer	0.000167	0.00201	CcSEcCtD
Ticlopidine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000167	0.00201	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000167	0.00201	CcSEcCtD
Ticlopidine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000167	0.00201	CcSEcCtD
Ticlopidine—Asthenia—Thiotepa—urinary bladder cancer	0.000167	0.00201	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000166	0.002	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—urinary bladder cancer	0.000166	0.002	CcSEcCtD
Ticlopidine—Pruritus—Thiotepa—urinary bladder cancer	0.000164	0.00198	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—urinary bladder cancer	0.000164	0.00198	CcSEcCtD
Ticlopidine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000163	0.00197	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000163	0.00196	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000163	0.00196	CcSEcCtD
Ticlopidine—Anorexia—Etoposide—urinary bladder cancer	0.000159	0.00192	CcSEcCtD
Ticlopidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000159	0.00192	CcSEcCtD
Ticlopidine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000158	0.00191	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000156	0.00188	CcSEcCtD
Ticlopidine—Pain—Cisplatin—urinary bladder cancer	0.000156	0.00188	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000155	0.00187	CcSEcCtD
Ticlopidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000154	0.00186	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—urinary bladder cancer	0.000154	0.00186	CcSEcCtD
Ticlopidine—Dizziness—Thiotepa—urinary bladder cancer	0.000154	0.00185	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000153	0.00185	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—urinary bladder cancer	0.000153	0.00184	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000152	0.00183	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000151	0.00182	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—urinary bladder cancer	0.000149	0.0018	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—urinary bladder cancer	0.000148	0.00178	CcSEcCtD
Ticlopidine—Vomiting—Thiotepa—urinary bladder cancer	0.000148	0.00178	CcSEcCtD
Ticlopidine—Rash—Thiotepa—urinary bladder cancer	0.000146	0.00177	CcSEcCtD
Ticlopidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000146	0.00176	CcSEcCtD
Ticlopidine—Headache—Thiotepa—urinary bladder cancer	0.000146	0.00175	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000145	0.00175	CcSEcCtD
Ticlopidine—Decreased appetite—Etoposide—urinary bladder cancer	0.000145	0.00175	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000145	0.00174	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—urinary bladder cancer	0.000144	0.00174	CcSEcCtD
Ticlopidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000144	0.00174	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000144	0.00173	CcSEcCtD
Ticlopidine—Pain—Etoposide—urinary bladder cancer	0.000143	0.00172	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000142	0.00171	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000141	0.0017	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000141	0.0017	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000141	0.0017	CcSEcCtD
Ticlopidine—Asthenia—Gemcitabine—urinary bladder cancer	0.00014	0.00169	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—urinary bladder cancer	0.00014	0.00169	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—urinary bladder cancer	0.000138	0.00167	CcSEcCtD
Ticlopidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000138	0.00167	CcSEcCtD
Ticlopidine—Nausea—Thiotepa—urinary bladder cancer	0.000138	0.00166	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000136	0.00165	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000136	0.00164	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000135	0.00162	CcSEcCtD
Ticlopidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000134	0.00162	CcSEcCtD
Ticlopidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000134	0.00161	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—urinary bladder cancer	0.000133	0.00161	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000133	0.0016	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000133	0.0016	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—urinary bladder cancer	0.000133	0.0016	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000132	0.0016	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000132	0.00159	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000132	0.00159	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000132	0.00159	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000131	0.00158	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—urinary bladder cancer	0.000131	0.00158	CcSEcCtD
Ticlopidine—Asthenia—Cisplatin—urinary bladder cancer	0.000131	0.00158	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—urinary bladder cancer	0.000129	0.00156	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000128	0.00154	CcSEcCtD
Ticlopidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000127	0.00153	CcSEcCtD
Ticlopidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000125	0.0015	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000124	0.0015	CcSEcCtD
Ticlopidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000124	0.0015	CcSEcCtD
Ticlopidine—Rash—Gemcitabine—urinary bladder cancer	0.000123	0.00149	CcSEcCtD
Ticlopidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000123	0.00148	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000123	0.00148	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—urinary bladder cancer	0.000123	0.00148	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000122	0.00148	CcSEcCtD
Ticlopidine—Headache—Gemcitabine—urinary bladder cancer	0.000122	0.00148	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000122	0.00147	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000122	0.00147	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000122	0.00147	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—urinary bladder cancer	0.000121	0.00146	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000121	0.00146	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—urinary bladder cancer	0.00012	0.00145	CcSEcCtD
Ticlopidine—Asthenia—Etoposide—urinary bladder cancer	0.00012	0.00144	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—urinary bladder cancer	0.000118	0.00142	CcSEcCtD
Ticlopidine—Nausea—Gemcitabine—urinary bladder cancer	0.000116	0.0014	CcSEcCtD
Ticlopidine—Vomiting—Cisplatin—urinary bladder cancer	0.000116	0.0014	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000115	0.00139	CcSEcCtD
Ticlopidine—Rash—Cisplatin—urinary bladder cancer	0.000115	0.00138	CcSEcCtD
Ticlopidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000115	0.00138	CcSEcCtD
Ticlopidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000114	0.00138	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—urinary bladder cancer	0.000114	0.00138	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000114	0.00137	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—urinary bladder cancer	0.000113	0.00136	CcSEcCtD
Ticlopidine—Dizziness—Etoposide—urinary bladder cancer	0.00011	0.00133	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—urinary bladder cancer	0.00011	0.00133	CcSEcCtD
Ticlopidine—Nausea—Cisplatin—urinary bladder cancer	0.000108	0.0013	CcSEcCtD
Ticlopidine—Vomiting—Etoposide—urinary bladder cancer	0.000106	0.00128	CcSEcCtD
Ticlopidine—Rash—Etoposide—urinary bladder cancer	0.000105	0.00127	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—urinary bladder cancer	0.000105	0.00127	CcSEcCtD
Ticlopidine—Headache—Etoposide—urinary bladder cancer	0.000105	0.00126	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—urinary bladder cancer	0.000104	0.00126	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—urinary bladder cancer	0.000104	0.00126	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000104	0.00126	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000102	0.00123	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	9.99e-05	0.00121	CcSEcCtD
Ticlopidine—Nausea—Etoposide—urinary bladder cancer	9.91e-05	0.00119	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	9.79e-05	0.00118	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—urinary bladder cancer	9.76e-05	0.00118	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—urinary bladder cancer	9.76e-05	0.00118	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—urinary bladder cancer	9.53e-05	0.00115	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	9.35e-05	0.00113	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.16e-05	0.0011	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.11e-05	0.0011	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—urinary bladder cancer	9.03e-05	0.00109	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—urinary bladder cancer	9.03e-05	0.00109	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—urinary bladder cancer	8.92e-05	0.00107	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—urinary bladder cancer	8.8e-05	0.00106	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—urinary bladder cancer	8.69e-05	0.00105	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	8.65e-05	0.00104	CcSEcCtD
Ticlopidine—Pain—Methotrexate—urinary bladder cancer	8.55e-05	0.00103	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.52e-05	0.00103	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.47e-05	0.00102	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—urinary bladder cancer	8.25e-05	0.000995	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—urinary bladder cancer	8.23e-05	0.000993	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.17e-05	0.000985	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—urinary bladder cancer	8.13e-05	0.00098	CcSEcCtD
Ticlopidine—Pain—Epirubicin—urinary bladder cancer	8e-05	0.000964	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—urinary bladder cancer	7.94e-05	0.000957	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—urinary bladder cancer	7.9e-05	0.000953	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.88e-05	0.000951	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.65e-05	0.000922	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—urinary bladder cancer	7.62e-05	0.000918	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—urinary bladder cancer	7.52e-05	0.000907	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—urinary bladder cancer	7.43e-05	0.000896	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—urinary bladder cancer	7.4e-05	0.000892	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—urinary bladder cancer	7.39e-05	0.000891	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—urinary bladder cancer	7.36e-05	0.000888	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—urinary bladder cancer	7.17e-05	0.000865	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.08e-05	0.000853	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—urinary bladder cancer	7.07e-05	0.000853	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—urinary bladder cancer	6.89e-05	0.000831	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—urinary bladder cancer	6.88e-05	0.000829	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—urinary bladder cancer	6.84e-05	0.000825	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—urinary bladder cancer	6.84e-05	0.000824	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—urinary bladder cancer	6.71e-05	0.000809	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—urinary bladder cancer	6.62e-05	0.000798	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—urinary bladder cancer	6.61e-05	0.000797	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—urinary bladder cancer	6.4e-05	0.000772	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.38e-05	0.000769	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—urinary bladder cancer	6.35e-05	0.000766	CcSEcCtD
Ticlopidine—Rash—Methotrexate—urinary bladder cancer	6.3e-05	0.00076	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—urinary bladder cancer	6.3e-05	0.000759	CcSEcCtD
Ticlopidine—Headache—Methotrexate—urinary bladder cancer	6.26e-05	0.000755	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—urinary bladder cancer	6.21e-05	0.000749	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—urinary bladder cancer	6.18e-05	0.000746	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—urinary bladder cancer	6.12e-05	0.000738	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—urinary bladder cancer	5.95e-05	0.000717	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—urinary bladder cancer	5.94e-05	0.000716	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—urinary bladder cancer	5.92e-05	0.000714	CcSEcCtD
Ticlopidine—Rash—Epirubicin—urinary bladder cancer	5.9e-05	0.000711	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—urinary bladder cancer	5.89e-05	0.00071	CcSEcCtD
Ticlopidine—Headache—Epirubicin—urinary bladder cancer	5.86e-05	0.000706	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—urinary bladder cancer	5.72e-05	0.00069	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—urinary bladder cancer	5.56e-05	0.00067	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—urinary bladder cancer	5.5e-05	0.000663	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—urinary bladder cancer	5.46e-05	0.000658	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—urinary bladder cancer	5.45e-05	0.000657	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—urinary bladder cancer	5.42e-05	0.000654	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—urinary bladder cancer	5.14e-05	0.00062	CcSEcCtD
Ticlopidine—P2RY12—Signaling Pathways—FGFR3—urinary bladder cancer	1.93e-05	0.000284	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	1.88e-05	0.000277	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ESR1—urinary bladder cancer	1.87e-05	0.000275	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	1.84e-05	0.000271	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	1.83e-05	0.000269	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	1.83e-05	0.000269	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.83e-05	0.000269	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.8e-05	0.000265	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.78e-05	0.000262	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.78e-05	0.000262	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.76e-05	0.000259	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.74e-05	0.000256	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMP—urinary bladder cancer	1.74e-05	0.000256	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	1.7e-05	0.00025	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.68e-05	0.000247	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	1.67e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.67e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	1.67e-05	0.000245	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.67e-05	0.000245	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CREBBP—urinary bladder cancer	1.64e-05	0.000241	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.64e-05	0.000241	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.62e-05	0.000239	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IGF1—urinary bladder cancer	1.62e-05	0.000238	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—EGFR—urinary bladder cancer	1.61e-05	0.000237	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.6e-05	0.000235	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.59e-05	0.000234	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NAT2—urinary bladder cancer	1.57e-05	0.000231	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.53e-05	0.000225	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—KRAS—urinary bladder cancer	1.52e-05	0.000224	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.51e-05	0.000222	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.49e-05	0.000219	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—RHOA—urinary bladder cancer	1.49e-05	0.000218	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.47e-05	0.000216	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.44e-05	0.000212	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.44e-05	0.000212	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.43e-05	0.00021	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.42e-05	0.000209	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.42e-05	0.000209	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.41e-05	0.000208	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.41e-05	0.000208	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.39e-05	0.000204	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ERBB2—urinary bladder cancer	1.38e-05	0.000202	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.37e-05	0.000201	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.36e-05	0.0002	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.36e-05	0.0002	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.0002	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.000196	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.000196	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.32e-05	0.000194	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.31e-05	0.000192	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL8—urinary bladder cancer	1.3e-05	0.000192	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.3e-05	0.000191	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.000191	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRAS—urinary bladder cancer	1.3e-05	0.000191	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.00019	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.29e-05	0.00019	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.29e-05	0.000189	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000185	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000185	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.25e-05	0.000184	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2—urinary bladder cancer	1.25e-05	0.000183	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.25e-05	0.000183	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.24e-05	0.000183	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000179	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—urinary bladder cancer	1.21e-05	0.000179	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.2e-05	0.000177	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.18e-05	0.000174	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—urinary bladder cancer	1.18e-05	0.000173	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1A—urinary bladder cancer	1.18e-05	0.000173	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.17e-05	0.000173	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—urinary bladder cancer	1.17e-05	0.000172	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.16e-05	0.000171	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.15e-05	0.000169	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.15e-05	0.000169	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.15e-05	0.000168	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EP300—urinary bladder cancer	1.12e-05	0.000164	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.12e-05	0.000164	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.11e-05	0.000164	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.11e-05	0.000163	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.11e-05	0.000163	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.1e-05	0.000162	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.1e-05	0.000162	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.1e-05	0.000161	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SRC—urinary bladder cancer	1.09e-05	0.00016	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000158	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.07e-05	0.000157	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.06e-05	0.000157	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.03e-05	0.000151	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.03e-05	0.000151	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.02e-05	0.00015	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.02e-05	0.00015	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.01e-05	0.000149	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.01e-05	0.000149	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1e-05	0.000147	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	9.98e-06	0.000147	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.83e-06	0.000145	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.83e-06	0.000144	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—urinary bladder cancer	9.75e-06	0.000143	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—urinary bladder cancer	9.53e-06	0.00014	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	9.46e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	9.46e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	9.38e-06	0.000138	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	9.38e-06	0.000138	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.33e-06	0.000137	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	9.29e-06	0.000137	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	9.18e-06	0.000135	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	9.15e-06	0.000135	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	9.1e-06	0.000134	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.01e-06	0.000133	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—urinary bladder cancer	9e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	8.96e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.96e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	8.66e-06	0.000127	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.57e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	8.56e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	8.51e-06	0.000125	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	8.45e-06	0.000124	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	8.41e-06	0.000124	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	8.41e-06	0.000124	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	8.33e-06	0.000123	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	8.29e-06	0.000122	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	8.24e-06	0.000121	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	8.24e-06	0.000121	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.18e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	8.05e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.05e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	8.02e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	8.02e-06	0.000118	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—urinary bladder cancer	8e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.97e-06	0.000117	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	7.91e-06	0.000116	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	7.89e-06	0.000116	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.86e-06	0.000116	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	7.86e-06	0.000116	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	7.77e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	7.77e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	7.77e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	7.75e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	7.75e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	7.74e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.66e-06	0.000113	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—urinary bladder cancer	7.65e-06	0.000113	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	7.63e-06	0.000112	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	7.56e-06	0.000111	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.5e-06	0.00011	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	7.44e-06	0.000109	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	7.43e-06	0.000109	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.34e-06	0.000108	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	7.3e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	7.28e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	7.2e-06	0.000106	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	7.12e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	7.12e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.02e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	6.92e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	6.86e-06	0.000101	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	6.82e-06	0.0001	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	6.69e-06	9.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.69e-06	9.84e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	6.68e-06	9.82e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	6.46e-06	9.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	6.43e-06	9.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.4e-06	9.41e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	6.36e-06	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	6.36e-06	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	6.36e-06	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.31e-06	9.27e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	6.29e-06	9.25e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.27e-06	9.22e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.19e-06	9.1e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.19e-06	9.1e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.1e-06	8.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	6.09e-06	8.95e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	6.03e-06	8.86e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6e-06	8.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	5.98e-06	8.79e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	5.91e-06	8.7e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	5.9e-06	8.68e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	5.86e-06	8.62e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	5.85e-06	8.6e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	5.85e-06	8.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	5.8e-06	8.52e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	5.8e-06	8.52e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	5.79e-06	8.51e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	5.67e-06	8.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	5.62e-06	8.26e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	5.6e-06	8.23e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	5.57e-06	8.18e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	5.55e-06	8.16e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	5.5e-06	8.08e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.47e-06	8.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.45e-06	8.01e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.39e-06	7.92e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	5.35e-06	7.86e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.21e-06	7.67e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.17e-06	7.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.12e-06	7.53e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.1e-06	7.5e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	5.01e-06	7.37e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.99e-06	7.33e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.95e-06	7.28e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.95e-06	7.28e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	4.9e-06	7.21e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	4.74e-06	6.97e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	4.74e-06	6.97e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	4.66e-06	6.85e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	4.64e-06	6.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	4.55e-06	6.7e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	4.38e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.38e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	4.38e-06	6.43e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.19e-06	6.16e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.16e-06	6.12e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.15e-06	6.11e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	4.14e-06	6.08e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.05e-06	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.02e-06	5.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.01e-06	5.9e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.99e-06	5.87e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.94e-06	5.8e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.87e-06	5.69e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—urinary bladder cancer	3.86e-06	5.68e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.82e-06	5.62e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.82e-06	5.62e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	3.82e-06	5.62e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.66e-06	5.38e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—urinary bladder cancer	3.64e-06	5.36e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.59e-06	5.28e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.58e-06	5.27e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.55e-06	5.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.5e-06	5.15e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.41e-06	5.01e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.38e-06	4.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.34e-06	4.91e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.3e-06	4.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.27e-06	4.8e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.12e-06	4.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.98e-06	4.38e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.87e-06	4.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.85e-06	4.19e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.79e-06	4.11e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.74e-06	4.03e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.74e-06	4.03e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.72e-06	4e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.63e-06	3.87e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.43e-06	3.58e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.15e-06	3.17e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.88e-06	2.76e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.79e-06	2.64e-05	CbGpPWpGaD
